Fostering interdisciplinary/transdisciplinary collaborations in cancer health economics research
BREAKOUT SESSION: Fostering interdisciplinary/transdisciplinary collaborations in cancer health economics research will focus discussion on 1) identifying barriers and facilitators to effective collaborations across disciplines in the context of health economics research and 2) identifying “public goods” that could help to address those barriers and support collaborations across disciplines. Additionally, we hope to provide a forum to launch collaborations among participants.
Development, organization, and structure of training programs for cancer health economics research
BREAKOUT SESSION: Join us for a conversation on training the next generation of cancer-focused health economists. We are an NCI Cancer Prevention Postdoctoral Fellow, a cancer-focused health services researcher and doctoral program director, and the Director of NCI’s Center for Cancer Training. We would like to hear your thoughts on what works, what doesn’t, and what is missing – help us describe an ideal approach.
Methods and study design for cancer health economics research
BREAKOUT SESSION: Methods and Study Designs will focus on a wide range of compelling topics, including the challenges when analyzing health care costs, determining causal inference, and estimating treatment effects from observational data, as well as effectiveness modelling and value assessment frameworks.
Improving data accessibility for health economics research without compromising data security
BREAKOUT SESSION: Health economists often use individual-level information when conducting cancer-related government policy or cancer care delivery research. Multi-level (e.g. state, healthcare system, facility, provider, patient, etc.) measures are needed as controls or covariates in regression models when evaluating a variety of policy or other environmental circumstances that the individual is exposed to. While these quasi-experimental regression designs are generally strong, a concern with this type of research is the accidental disclosure of patient or entity identifiers. Join us for a conversation regarding the challenges, possible opportunities, and development of potential recommendations on how to improve access to, while ensuring confidentiality of, government-funded and privately-collected data for health economists doing cancer research.
